首页> 外文期刊>Journal of minimally invasive gynecology >Pain relief by continuous intraperitoneal nebulization of ropivacaine during gynecologic laparoscopic surgery--a randomized study and review of the literature.
【24h】

Pain relief by continuous intraperitoneal nebulization of ropivacaine during gynecologic laparoscopic surgery--a randomized study and review of the literature.

机译:妇科腹腔镜手术中罗哌卡因持续腹膜内雾化可减轻疼痛-一项随机研究并文献复习。

获取原文
获取原文并翻译 | 示例
       

摘要

STUDY OBJECTIVE: To evaluate the efficacy of intraperitoneal nebulization of ropivacaine on pain relief during and after gynecologic laparoscopic procedures including a review of the literature. DESIGN: Double-blinded, randomized, controlled, clinical trial (Canadian Task Force classification I). SETTING: University hospital ambulatory gynecoendoscopic department. PATIENTS: Forty patients (20 patients in each arm) undergoing elective gynecologic same-day outpatient laparoscopic surgery including unilateral/bilateral salpingo-oophorectomy or unilateral/bilateral ovarian cystectomy. INTERVENTIONS: The study group received 10 mL of 1% ropivacaine and the control group received 10 mL of sterile water by intraperitoneal nebulization. During surgery, vital signs were recorded and summarized. Postoperatively patients were followed up for 24 hours including visual analog scale scores and analgesic use. MEASUREMENTS AND MAIN RESULTS: No significant differences existed between the groups during surgery and at the recovery department in terms of arterial blood pressure (p=.42) or heart rate (p=.60). Regarding postoperative analgesia, no difference existed between the groups in terms of morphine consumption (p=.52) or other analgesics (p=.53). No significant difference existed between the groups in postoperative visual analog scale scores including visceral, abdominal wall, and shoulder pain during rest and during cough at the different time frames (30, 60, and 120 minutes and 6 and 24 hours after surgery). CONCLUSION: Our study is the first to examine the effects of intraperitoneal nebulization of ropivacaine throughout laparoscopic gynecologic procedures on patients undergoing general anesthesia. Nebulization of 100 mg of ropivacaine under our specific regimen of anesthesia does not improve patients' outcome in terms of intraoperative and postoperative pain along with consumption of analgesics. Further research with other regimens is required.
机译:目的:评价罗哌卡因腹膜内雾化对妇科腹腔镜手术过程中和术后疼痛的缓解作用,包括文献复习。设计:双盲,随机,对照临床试验(加拿大工作组I级)。单位:大学医院门诊妇科内镜科。患者:40例患者(每组20例患者)接受了妇科当天就诊的腹腔镜手术,包括单侧/双侧输卵管卵巢切除术或单侧/双侧卵巢膀胱切除术。干预措施:研究组通过腹膜内雾化接受10 mL 1%罗哌卡因,对照组接受10 mL无菌水。在手术过程中,记录并总结了生命体征。术后对患者进行24小时的随访,包括视觉模拟量表评分和止痛药的使用。测量和主要结果:手术期间和恢复部门的两组之间在动脉血压(p = .42)或心率(p = .60)方面均无显着差异。关于术后镇痛,两组之间在吗啡消耗量(p = .52)或其他镇痛剂(p = .53)方面没有差异。两组的术后视觉模拟量表评分(包括内脏,腹壁和肩膀疼痛)在休息时间和咳嗽过程中在不同时间段(手术后30分钟,60分钟和120分钟以及手术后6小时和24小时)没有显着差异。结论:我们的研究是第一个检查罗哌卡因腹腔镜在妇科腹腔镜手术中对全麻患者的影响。在我们特定的麻醉方案下雾化100 mg罗哌卡因在术中和术后疼痛以及服用止痛药方面并未改善患者的预后。需要与其他方案进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号